
Fiona Powers
Examiner (ID: 2024)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1626, 1201, 1613, 2899 |
| Total Applications | 2100 |
| Issued Applications | 1653 |
| Pending Applications | 85 |
| Abandoned Applications | 362 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5961804
[patent_doc_number] => 20110146693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-23
[patent_title] => 'INTRAUTERINE DELIVERY SYSTEM FOR CONTRACEPTION'
[patent_app_type] => utility
[patent_app_number] => 12/995905
[patent_app_country] => US
[patent_app_date] => 2009-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7775
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20110146693.pdf
[firstpage_image] =>[orig_patent_app_number] => 12995905
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/995905 | INTRAUTERINE DELIVERY SYSTEM FOR CONTRACEPTION | Jun 30, 2009 | Abandoned |
Array
(
[id] => 6142065
[patent_doc_number] => 20110129429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-02
[patent_title] => 'Water-Containing Composition'
[patent_app_type] => utility
[patent_app_number] => 13/002005
[patent_app_country] => US
[patent_app_date] => 2009-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8365
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20110129429.pdf
[firstpage_image] =>[orig_patent_app_number] => 13002005
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/002005 | Water-Containing Composition | Jun 30, 2009 | Abandoned |
Array
(
[id] => 11414494
[patent_doc_number] => 09561304
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-07
[patent_title] => 'Combination of blood and of biphasic calcium phosphate ceramic particles'
[patent_app_type] => utility
[patent_app_number] => 13/001055
[patent_app_country] => US
[patent_app_date] => 2009-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9025
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13001055
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/001055 | Combination of blood and of biphasic calcium phosphate ceramic particles | Jun 21, 2009 | Issued |
Array
(
[id] => 5457877
[patent_doc_number] => 20090258029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'Heparin Prodrugs and Drug Delivery Stents Formed Therefrom'
[patent_app_type] => utility
[patent_app_number] => 12/489205
[patent_app_country] => US
[patent_app_date] => 2009-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5592
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258029.pdf
[firstpage_image] =>[orig_patent_app_number] => 12489205
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/489205 | Heparin prodrugs and drug delivery stents formed therefrom | Jun 21, 2009 | Issued |
Array
(
[id] => 5457902
[patent_doc_number] => 20090258054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'Heparin Prodrugs and Drug Delivery Stents Formed Therefrom'
[patent_app_type] => utility
[patent_app_number] => 12/489219
[patent_app_country] => US
[patent_app_date] => 2009-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5832
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258054.pdf
[firstpage_image] =>[orig_patent_app_number] => 12489219
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/489219 | Heparin prodrugs and drug delivery stents formed therefrom | Jun 21, 2009 | Issued |
Array
(
[id] => 5457895
[patent_doc_number] => 20090258047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'Heparin Prodrugs and Drug Delivery Stents Formed Therefrom'
[patent_app_type] => utility
[patent_app_number] => 12/489224
[patent_app_country] => US
[patent_app_date] => 2009-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5593
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258047.pdf
[firstpage_image] =>[orig_patent_app_number] => 12489224
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/489224 | Heparin Prodrugs and Drug Delivery Stents Formed Therefrom | Jun 21, 2009 | Abandoned |
Array
(
[id] => 5457903
[patent_doc_number] => 20090258055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'Heparin Prodrugs and Drug Delivery Stents Formed Therefrom'
[patent_app_type] => utility
[patent_app_number] => 12/489227
[patent_app_country] => US
[patent_app_date] => 2009-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5593
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258055.pdf
[firstpage_image] =>[orig_patent_app_number] => 12489227
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/489227 | Heparin Prodrugs and Drug Delivery Stents Formed Therefrom | Jun 21, 2009 | Abandoned |
Array
(
[id] => 5367220
[patent_doc_number] => 20090304779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'MICRO-MEMBRANE IMPLANT WITH CUSPED OPENING'
[patent_app_type] => utility
[patent_app_number] => 12/480640
[patent_app_country] => US
[patent_app_date] => 2009-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9091
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0304/20090304779.pdf
[firstpage_image] =>[orig_patent_app_number] => 12480640
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/480640 | MICRO-MEMBRANE IMPLANT WITH CUSPED OPENING | Jun 7, 2009 | Abandoned |
Array
(
[id] => 6302685
[patent_doc_number] => 20100068266
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Ex vivo-modifiable multiple-release state final dosage form'
[patent_app_type] => utility
[patent_app_number] => 12/387326
[patent_app_country] => US
[patent_app_date] => 2009-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 68
[patent_figures_cnt] => 68
[patent_no_of_words] => 48854
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20100068266.pdf
[firstpage_image] =>[orig_patent_app_number] => 12387326
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/387326 | Ex vivo-modifiable multiple-release state final dosage form | Apr 28, 2009 | Abandoned |
Array
(
[id] => 6309421
[patent_doc_number] => 20100069887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Multiple chamber ex vivo adjustable-release final dosage form'
[patent_app_type] => utility
[patent_app_number] => 12/387324
[patent_app_country] => US
[patent_app_date] => 2009-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 68
[patent_figures_cnt] => 68
[patent_no_of_words] => 49057
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20100069887.pdf
[firstpage_image] =>[orig_patent_app_number] => 12387324
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/387324 | Multiple chamber ex vivo adjustable-release final dosage form | Apr 28, 2009 | Abandoned |
Array
(
[id] => 6309157
[patent_doc_number] => 20100069821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Ex vivo modifiable medicament release-sites final dosage form'
[patent_app_type] => utility
[patent_app_number] => 12/387323
[patent_app_country] => US
[patent_app_date] => 2009-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 68
[patent_figures_cnt] => 68
[patent_no_of_words] => 48854
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20100069821.pdf
[firstpage_image] =>[orig_patent_app_number] => 12387323
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/387323 | Ex vivo modifiable medicament release-sites final dosage form | Apr 28, 2009 | Abandoned |
Array
(
[id] => 6302764
[patent_doc_number] => 20100068283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Ex VIVO modifiable particle or polymeric material medicament carrier'
[patent_app_type] => utility
[patent_app_number] => 12/387312
[patent_app_country] => US
[patent_app_date] => 2009-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 67
[patent_figures_cnt] => 67
[patent_no_of_words] => 48120
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20100068283.pdf
[firstpage_image] =>[orig_patent_app_number] => 12387312
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/387312 | Ex VIVO modifiable particle or polymeric material medicament carrier | Apr 28, 2009 | Abandoned |
Array
(
[id] => 6302634
[patent_doc_number] => 20100068256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Ex vivo modifiable medicament release-substance'
[patent_app_type] => utility
[patent_app_number] => 12/387311
[patent_app_country] => US
[patent_app_date] => 2009-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 68
[patent_figures_cnt] => 68
[patent_no_of_words] => 48846
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20100068256.pdf
[firstpage_image] =>[orig_patent_app_number] => 12387311
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/387311 | Ex vivo modifiable medicament release-substance | Apr 28, 2009 | Abandoned |
Array
(
[id] => 5480770
[patent_doc_number] => 20090203727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'NOVEL PHARMACEUTICAL COMPOSITION AND ITS USE IN A METHOD FOR TREATMENT OF PATIENTS WITH UPPER RESPIRATORY MUCOSAL CONGESTION'
[patent_app_type] => utility
[patent_app_number] => 12/424765
[patent_app_country] => US
[patent_app_date] => 2009-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3327
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203727.pdf
[firstpage_image] =>[orig_patent_app_number] => 12424765
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/424765 | NOVEL PHARMACEUTICAL COMPOSITION AND ITS USE IN A METHOD FOR TREATMENT OF PATIENTS WITH UPPER RESPIRATORY MUCOSAL CONGESTION | Apr 15, 2009 | Abandoned |
Array
(
[id] => 9440356
[patent_doc_number] => 08709465
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-29
[patent_title] => 'Diazeniumdiolated phosphorylcholine polymers for nitric oxide release'
[patent_app_type] => utility
[patent_app_number] => 12/422425
[patent_app_country] => US
[patent_app_date] => 2009-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7228
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12422425
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/422425 | Diazeniumdiolated phosphorylcholine polymers for nitric oxide release | Apr 12, 2009 | Issued |
Array
(
[id] => 5342419
[patent_doc_number] => 20090181069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'THIN FILM WITH NON-SELF-AGGREGATING UNIFORM HETEROGENEITY AND DRUG DELIVERY SYSTEMS MADE THEREFROM'
[patent_app_type] => utility
[patent_app_number] => 12/411505
[patent_app_country] => US
[patent_app_date] => 2009-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13773
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20090181069.pdf
[firstpage_image] =>[orig_patent_app_number] => 12411505
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/411505 | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom | Mar 25, 2009 | Issued |
Array
(
[id] => 6148667
[patent_doc_number] => 20110020262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'HAIR CONDITIONING COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 12/920115
[patent_app_country] => US
[patent_app_date] => 2009-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 968
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20110020262.pdf
[firstpage_image] =>[orig_patent_app_number] => 12920115
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/920115 | Hair conditioning composition | Mar 4, 2009 | Issued |
Array
(
[id] => 8244600
[patent_doc_number] => 08202526
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-19
[patent_title] => 'Prophylactic article'
[patent_app_type] => utility
[patent_app_number] => 12/389115
[patent_app_country] => US
[patent_app_date] => 2009-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5339
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/202/08202526.pdf
[firstpage_image] =>[orig_patent_app_number] => 12389115
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/389115 | Prophylactic article | Feb 18, 2009 | Issued |
Array
(
[id] => 6302077
[patent_doc_number] => 20100068153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Ex vivo activatable final dosage form'
[patent_app_type] => utility
[patent_app_number] => 12/322878
[patent_app_country] => US
[patent_app_date] => 2009-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 25218
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20100068153.pdf
[firstpage_image] =>[orig_patent_app_number] => 12322878
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/322878 | Ex vivo activatable final dosage form | Feb 4, 2009 | Abandoned |
Array
(
[id] => 6302622
[patent_doc_number] => 20100068254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Modifying a medicament availability state of a final dosage form'
[patent_app_type] => utility
[patent_app_number] => 12/322874
[patent_app_country] => US
[patent_app_date] => 2009-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 25213
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20100068254.pdf
[firstpage_image] =>[orig_patent_app_number] => 12322874
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/322874 | Modifying a medicament availability state of a final dosage form | Feb 4, 2009 | Abandoned |